United States News All stories

AerCap (NYSE:AER) delivered the first new GE-powered Boeing 787-9 aircraft to Thai Airways on June 23, 2026 at Boeing’s Delivery Center in Everett, Seattle.

Korn Ferry (NYSE:KFY) reported fourth quarter FY'26 fee revenue of $759.8 million, a 7% increase from the prior year.

Applied Industrial Technologies (NYSE:AIT) announced a quarterly cash dividend of $0.51 per common share to reward its equity investors.

Teleflex Incorporated (NYSE:TFX) announced the beginning of enrollment in the BIOMAG-III Study, a global pivotal trial evaluating the Freesolve Resorbable Magnesium Scaffold (RMS).

Jiayin Group (NASDAQ:JFIN) reported first quarter 2026 unaudited results with transaction volume of RMB19.3 billion, a 45.8% decrease from the prior year.

Dorian LPG (NYSE:LPG) entered into an agreement with HD Hyundai to construct one 90,000 cbm very large gas carrier for delivery in July 2029 at a price of approximately $115 million.

AEVEX (NYSE:AVEX) has been awarded the next option year of the Fire Integrated Real-Time Intelligence System (FIRIS) contract by the California Governor’s Office of Emergency Services (Cal OES), valued at $15.2 million.

Organon (NYSE:OGN) and Shanghai Henlius Biotech, made BILDYOS (denosumab injection) 60 mg/1 mL and TUZEMTY (denosumab injection) 120 mg/1.7 mL available in Canada.

AbbVie (NYSE:ABBV) said the European Commission has granted approval for its oral antiviral MAVIRET (glecaprevir/pibrentasvir) to treat acute hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older with compensated liver disease, with or without cirrhosis.

Brent crude futures fell $1.09, or 1.4%, to $76.81 a barrel, while U.S. West Texas Intermediate crude declined 87 cents, or 1.2%, to $72.99 a barrel as of 0607 GMT.

Keurig Dr Pepper (NASDAQ:KDP) disclosed executive changes as it advances plans to separate its beverage and coffee businesses into two standalone companies in early 2027.

AbbVie (NYSE:ABBV) secured European Commission approval for SKYRIZI to treat pediatric plaque psoriasis patients aged six and older.

Technology stocks came under heavy selling pressure with Nasdaq 100 futures pointing to a 2.8% decline and S&P 500 futures down 1.4%.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced today that the European Commission has granted marketing authorization for REDEMPLO (plozasiran) as an adjunct to diet for treating adults with familial chylomicronemia syndrome (FCS).

HII (NYSE:HII) announced today that its Mission Technologies division has received a $418 million, five-year indefinite delivery/indefinite quantity (IDIQ) contract to support U.S. Navy fleet operational readiness.

Eli Lilly (NYSE:LLY) announced that its board of directors has declared a cash dividend of $1.73 per share on outstanding common stock for the third quarter of 2026.

SpaceX (NASDAQ:SPCX) has initiated its first-ever bond sale to repay outstanding debt following a 7% decline in its share price during early Monday trade.

INVO Fertility (NASDAQ:IVF) recorded a 23% increase in year-over-year revenue to $2.02 million for the first quarter of 2026.

NRx Pharmaceuticals (NASDAQ:NRXP) secured FDA authorization for a depression treatment protocol with an initial drug cost of $0.

TScan Therapeutics (NASDAQ:TCRX) reported initial clinical trial data showing 11 out of 14 blood cancer patients achieved complete donor chimerism.

Eledon Pharmaceuticals (NASDAQ:ELDN) reported extension data showing a 12 mL/min kidney function advantage at 18 months.

Clinical-stage biopharmaceutical firm Traws Pharma (NASDAQ:TRAW) updated guidance for its influenza prophylaxis program to enable a planned Phase 2a trial.

Workforce solutions provider Atlantic International (NASDAQ:ATLN) reported first-quarter 2026 revenue of $249.9 million.

Biopharmaceutical firm Nuvectis (NASDAQ:NVCT) licensed exclusive ex-China rights for two clinical drug assets in a deal valued up to $1.461 billion.